Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 0.00 0.00%
S&P 500 1,878.61 3.22 0.17%
NASDAQ 4,148.34 21.37 0.52%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,512.47 107.48 0.75%
TOPIX 1,174.20 9.30 0.80%
HANG SENG 22,442.36 -120.44 -0.53%

MERCK SERONO, QUINTILES ANNOUNCE CLINICAL DEV PARTNERSHIP (ENG)


(The following press release from Merck Serono was received by e-mail. It was not confirmed by the sender.)

News Release

Your Contact Heather Connor +1 978-294-1660

Merck Serono and Quintiles Announce Innovative Clinical Development Partnership

• Agreement creates unique strategic collaboration for development and clinical trial execution

Darmstadt, Germany, May 15, 2013 – Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, the world’s largest provider of biopharmaceutical development and commercial outsourcing services, today announced a new, five-year clinical development agreement. This strategic collaboration is the first-of-its-kind between a biopharmaceutical company and a biopharmaceutical services provider, creating a comprehensive process that integrates the expertise and experience from both organizations into a single, well-aligned clinical development engine.

The complete news release can be downloaded at the following link: http://news.merck.de/N/0/AE71F0E60400CA7EC1257B6C002F49A5/$File/MerckSerono_Quin tiles.pdf

News releases from Merck KGaA, Darmstadt, Germany, are available at this address: www.merckgroup.com/media or for residents in the USA and Canada at www.emdgroup.com/media

In case you are a resident of the USA or Canada please go to http://www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email.

You may change your subscription at any time by following either one of the following links: www.merckgroup.com/subscribe or www.emdgroup.com/subscribe And please feel free to unsubscribe this service with either www.merckgroup.com/subscribe or www.emdgroup.com/unsubscribe Thank you very much!

Merck KGaA ,Darmstadt, Germany External Communications E-mail: Media.Relations@merck.de Hotline: +49 (0) 6151/72-5000

This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith.

Click http://disclaimer.merck.de to access the German, French, Spanish and Portuguese versions of this disclaimer.

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement